Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
04/04/2002 | WO2002026258A2 Treatment of immune-mediated diseases by oral administration of plasma fractions |
04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
04/04/2002 | WO2002026217A2 Composition for the transdermal delivery of fentanyl |
04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
04/04/2002 | WO2002000662B1 Improvements in and relating to chromophores |
04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
04/04/2002 | WO2001097837A8 Solubilised protein vaccines |
04/04/2002 | WO2001097795A3 Systems and methods for treating a mucosal surface |
04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
04/04/2002 | WO2001089451A3 Protease inhibitors |
04/04/2002 | WO2001087376A8 Drug/drug delivery systems for the prevention and treatment of vascular disease |
04/04/2002 | WO2001087263A3 Delivery systems for treatment of vascular disease |
04/04/2002 | WO2001081332A3 2-fluorobenzenesulfonyl compounds for the treatment of inflammation |
04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
04/04/2002 | WO2001070678A3 Substituted biphenyl derivatives |
04/04/2002 | WO2001066098A3 Therapeutic uses of ppar mediators |
04/04/2002 | WO2001064896A3 Human enzyme molecules |
04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
04/04/2002 | WO2001048231A3 Method of achieving persistent transgene expression |
04/04/2002 | WO2001034182A3 Composition for treating respiratory tract infections containing menthol, eucalyptol and an alpha-amylase |
04/04/2002 | US20020040148 Diphenyl heterocyclic thioamide derivatives |
04/04/2002 | US20020040060 2'-methyl-biphenyl-2-carboxylic acid-(3,5-bis-trifluoromethyl-benzyl)-methyl-amide, for example; treating disease related to neurokinin 1 receptor |
04/04/2002 | US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example |
04/04/2002 | US20020040039 Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist |
04/04/2002 | US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
04/04/2002 | US20020040022 Administering a therapeutically effective amount of a heterocyclic compound to the patient for the treatment of inosine monophosphate dehydrogenase associated disorders, such as allograft rejection |
04/04/2002 | US20020040020 Substituted pyrazoles |
04/04/2002 | US20020040019 Substituted pyrazoles |
04/04/2002 | US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
04/04/2002 | US20020039560 Drug delivery |
04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
04/04/2002 | CA2423903A1 O-substituted 6-methyltramadol derivatives |
04/04/2002 | CA2423889A1 Methods and compositions for screening modulators of lipid kinases |
04/04/2002 | CA2423805A1 Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
04/04/2002 | CA2423704A1 G-protein coupled receptors |
04/04/2002 | CA2423694A1 Transferases |
04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
04/04/2002 | CA2423424A1 Secreted proteins |
04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
04/04/2002 | CA2421851A1 Tgf-.beta. inhibitors and methods |
04/04/2002 | CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
04/04/2002 | CA2420577A1 Peptide-based compounds |
04/04/2002 | CA2420475A1 Ige receptor antagonists |
04/03/2002 | EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
04/03/2002 | EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides |
04/03/2002 | EP1193261A1 New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
04/03/2002 | EP1193257A2 Compounds for ceramide-mediated signal transduction |
04/03/2002 | EP1193256A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins |
04/03/2002 | EP1193255A1 Heterocyclic compounds and medicinal use thereof |
04/03/2002 | EP1192939A2 Methods for reduction of inflammation and erythema |
04/03/2002 | EP1192271A1 Antisense modulation of interleukin-5 signal transduction |
04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
04/03/2002 | EP1192180A1 Product from starfish |
04/03/2002 | EP1192171A1 48 human secreted proteins |
04/03/2002 | EP1192170A1 Propargyl phenyl ether a2a receptor agonists |
04/03/2002 | EP1192150A1 New pharmaceutically active compounds |
04/03/2002 | EP1192147A1 Mycolactone and related compounds, compositions and methods of use |
04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
04/03/2002 | EP1192125A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
04/03/2002 | EP1191941A1 A method for the prophylaxis and/or treatment of medical disorders |
04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
04/03/2002 | EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1009393B1 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
04/03/2002 | EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
04/03/2002 | EP0873331B1 Benzofuran carboxamides and sulphonamides |
04/03/2002 | EP0775199B1 Superoxide dismutase-4 |
04/03/2002 | EP0716600B1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
04/03/2002 | EP0676962B9 Enhanced pharmaceutical compositions for skin penetration for piroxicam |
04/03/2002 | CN1343213A 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
04/03/2002 | CN1343212A Derivatives of monosaccharides as well adhesion inhibitors |
04/03/2002 | CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use |
04/03/2002 | CN1343206A Cyclocompound |
04/03/2002 | CN1343197A Biphenyl derivatives as antagonists of neurokinine-1 receptor |
04/03/2002 | CN1343174A 计量阀 Metering valve |
04/03/2002 | CN1343122A Remedies for joint diseases |
04/03/2002 | CN1342490A Process for preparing staltic-antagic medicine to treat trauma |
04/03/2002 | CN1342489A Liquid omphalotherapeutic medicine for treating abdominalgia |
04/03/2002 | CN1342486A Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
04/03/2002 | CN1342478A Medical wine for treating rheumatism |
04/03/2002 | CN1342472A Exterior-applied Chinese medicine for treating rheumatic and rheumatoid diseases |
04/03/2002 | CN1342471A Antalgic Bingchan ointment and its preparing process |
04/03/2002 | CN1342468A Capsule for treating rheumatic and rheumatoid arthritis and its preparing process |
04/03/2002 | CN1342462A Composite medicine for treating rheumatoid arthritis |
04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |